Novel M&A paths gaining acceptance

compares with more traditional, friendly mergers in the industry's past, such as the combinations of Pfizer and Wyeth, and the merger of Schering-Plough and Merck. Sanofi's hostile bid for Genzyme included another unusual twist -- a milestone payout that...